Cytonics

About:

Cytonics is a biotechnology company developing diagnostic assays focusing on musculoskeletal-related pain.

Top Investors: SeedInvest, NIAMS, Rainmakers

Description:

Cytonics Corporation, a biotechnology company, develops diagnostic assays focusing on musculoskeletal related pain. It offers Fibronectin Aggrecan Complex Test (FACT) for molecular discography and FACT Plus multi analyte assay for diagnosing the source of pain in the spine and joints. Additionally, the company provides proteomics research and development services. Cytonics Corporation was founded in 2006 and is based in Jupiter, Florida.

Total Funding Amount:

$5.7M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Jupiter, Florida, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)cytonics.com

Founders:

Gaetano Scuderi, Peter Simonson

Number of Employees:

1-10

Last Funding Date:

2019-05-18

IPO Status:

Private

Industries: